 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
|
|
 |
|
|
 |
Have a question
or comment?
Want to tell us what we’re doing right
or how we can make OvCa.net better? |
|
Let us know! |
|
|
|
|
|
Brought to us by Joan Tomabene.
- ACOR: Association of Cancer Online Resources
- ACS: American Cancer Society
- AFP: Alpha FetoProtein
- AICR: American Institute for Cancer Research
- ALT: Alternative
- BC: Breast cancer [BRCA is preferred]
- BMT: Bone marrow transplant
- BRCA: Breast cancer
- BRCA1: Breast cancer 1 tumor suppressor gene for breast, ovarian
cancers
- BRCA2: Breast cancer 2 tumor suppressor gene for breast cancer
- BSE: Breast self-examination
- Bx: Biopsy
- CA 19-9: Cancer antigen 19-9
- CA 125: Cancer antigen 125
- CAT: Computerized Axial Tomography
- CBC: Complete blood count
- CCDRT: Cell Culture Drug Resistance Testing (in vitro assay of
fresh tumor and various chemos used to identify chemos that
might NOT be effective as follow-up therapy)
- CDI: Color Doppler Imaging
- CEA: Carcinoembryonic Antigen
- CFS: Chronic Fatigue Syndrome
- CHF: Congestive Heart Failure
- CICU: Coronary intensive care unit
- CIN: Cervical intraepithelial neoplasm
- CMV: Cytomegalovirus (a form of pneumonia)
- CNS: Central nervous system
- CT: Computed Tomography; also Clinical trial
- DIAG: Diagnosis
- DM70K: New tumor marker especially sensitive for mucinous rather
than serous cell type tumors
- DVT: Deep vein thrombosis
- Dx: Diagnosis
- ED: Evidence of disease
- EGFR: Epidermal growth factor receptor, an ovca antigen
- ENDOCA: Endometrial cancer
- ERA: Estrogen Receptor Assay
- erb-B2: Oncogene for breast, salivary gland, ovarian cancers
- ERT: Estrogen replacement therapy
- EVA: Ex Vivo Apoptotic Assay (uses live cells vs. dead cells and
a cytotoxicity test that exposes tumor cells for four days)
- FDA: Food & Drug Administration (U.S.)
- FIGO: International Federation of Gynecology and Obstetrics
- FTCA: Fallopian tube cancer
- G-CSF: Granulocyte colony-stimulating factor (stimulates production
of blood cells)
- GOG: Gynecologic Oncology Group
- gyn onc: Gynecological oncologist; gynecologist who specializes in
women's cancers
- HAHA: Human anti-human antibody
- HAMA: Human anti-murine (mouse) antibody
- HCG: Human chorionic gonadotropin
- HDC: High-dose chemotherapy
- HER2/neu: Gene that controls cell growth by making human epidermal
growth factor receptor 2 (c-erb-B2). See erb-B2.
- HRT: Hormone replacement therapy
- Hx: History
- ICU: Intensive care unit
- IP: Intraperitoneal (as in "intraperitoneal chemotherapy", chemo
placed directly into the peritoneal cavity).
- IR: Interventional radiology, surgical procedures done by radiologists
while they watch on their equipment
- IV: Intravenous
- IVF: In vitro fertilization
- IVP: Intravenous pyelogram
- ki-ras: Oncogene for lung, ovarian, colon, pancreatic cancers
- LFT: Liver function test
- LLN: Lower limit of normal
- LLQ: Left lower quadrant
- LMP: Low Malignant Potential (a type of ovarian cancer)
- LPA: Lysophosphatidic acid, a fat molecule that makes ovarian
tumors grow (new tumor marker for ovca)
- LUQ: Left upper quadrant
|
|
|
